Key result
Minimally invasive direct access heart valve surgery demonstrated low operative mortality (2% for aortic and 0.8% for mitral procedures) and low rates of perioperative complications.
Why the study?
Does minimally invasive direct access (MIDA) heart valve surgery provide safe and effective outcomes in patients requiring isolated elective aortic or mitral valve surgery?
Observational (n=518)
Does minimally invasive direct access (MIDA) heart valve surgery provide safe and effective outcomes in patients requiring isolated elective aortic or mitral valve surgery?
Minimally invasive direct access heart valve surgery is a safe and effective approach for isolated elective aortic or mitral valve procedures, with low operative mortality and good functional recovery.
Supports feasibility of MIDA valve surgery in selected patients; leaves open comparative efficacy versus sternotomy.
We review our experience with minimally invasive direct access (MIDA) heart valve surgery in 518 patients. Two hundred fifty-two patients underwent MIDA aortic valve replacement (AVR) or repair and 266 underwent MIDA mitral valve repair or replacement. Among the 250 AVRs, 157 (63%) were men, aged 63.2 +/- 14.6 years, NYHA functional Class 2.4 +/- 0.8. The surgical approach was right parasternal in 36 (14%) or upper hemisternotomy in 216 (86%). There were four (2%) operative deaths. Perioperative complications included 14 (5.6%) reexplorations for bleeding, 7 (3%) chest wound infections, 5 (2%) strokes, and 1 (0.4%) external iliac vein injury. Follow-up was complete in 193 (77%) patients, with a mean follow-up of 12 +/- 8 months. Late complications included 2 (0.8%) nonfatal myocardial infarctions, 4 (2%) reoperations for, respectively, 2 pericardial complications, 1 paravalvar leak, and 1 infected valve. There were five (2%) late deaths from congestive heart failure, pneumonia, hemorrhage, aneurysm, and cancer. Mean follow-up NYHA Class was 1.4 +/- 0.6. For the 266 mitral patients, 145 (54.5%) were men, age 58.7 +/- 13.6 years, functional Class 2.3 +/- 0.5. The surgical approach was right parasternal in 195 (73%), lower hemisternotomy in 53 (20%), right submammary thoracotomy in 9 (3.4%), or full sternotomy through a small skin incision in 9 (3.4%). There were 2 (0.8%) operative deaths. Perioperative complications included 4 (1.5%) reoperations for bleeding, 4 (1.5%) strokes, and 5 (2%) wound infections, and 3 (1%) ascending aortic complications. Follow-up was complete in 202 (76%) patients with a mean follow-up of 9.5 +/- 6.4 months. Late complications included one (0.4%) nonfatal myocardial infarction and three (1%) reoperations all converting repairs to replacements. There were three (1%) late deaths from suicide, pneumonia, and sudden death, respectively. Mean follow-up NYHA functional Class was 1.3 +/- 0.5. We conclude that MIDA heart valve surgery is safe and effective for the majority of patients requiring isolated elective aortic or mitral valve surgery.
No takes yet. Share an insight, caveat, or question.
Byrne et al. (2000) conducted an observational in Heart valve disease requiring surgery (n=518). Minimally invasive direct access (MIDA) heart valve surgery was evaluated on Operative mortality and complications. Minimally invasive direct access heart valve surgery demonstrated low operative mortality (2% for aortic and 0.8% for mitral procedures) and low rates of perioperative complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: